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Antibody Reactivity to Merozoite Antigens in Ghanaian 
Adults Correlates With Growth Inhibitory Activity Against 
Plasmodium falciparum in Culture
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Background. Plasmodium falciparum uses a repertoire of merozoite-stage proteins for invasion of erythrocytes. Antibodies 
against some of these proteins halt the replication cycle of the parasite by preventing erythrocyte invasion and are implicated as 
contributors to protective immunity against malaria.
Methods. We assayed antibody reactivity against a panel of 9 recombinant antigens based on erythrocyte-binding antigen (EBA) 
and reticulocyte-like homolog (Rh) proteins in plasma from children with malaria and healthy adults residing in 3 endemic areas in 
Ghana using enzyme-linked immunosorbent assay. Puriied immunoglobulin (Ig)G from adult plasma samples was also tested for 
invasion inhibition against 7 diferent P falciparum culture lines, including clinical isolates.
Results. Antibodies against the antigens increased in an age-dependent manner in children. Breadth of reactivity to the dif-
ferent antigens was strongly associated with in vitro parasite growth inhibitory activity of IgG puriied from the adults. he strongest 
predictors of breadth of antibody reactivity were age and transmission intensity, and a combination of reactivities to Rh2, Rh4, and 
Rh5 correlated strongly with invasion inhibition.
Conclusions. Growth inhibitory activity was signiicantly associated with breadth of antibody reactivity to merozoite antigens, 
encouraging the prospect of a multicomponent blood-stage vaccine.
Keywords:  falciparum malaria; growth inhibitory activity; humoral immunity; invasion; vaccine development.
There are over 200 million cases of malaria annually, resulting 
in approximately half a million deaths [1], the majority being 
caused by Plasmodium falciparum. The majority of ma-
laria cases and deaths occur in sub-Saharan Africa, affecting 
mainly children under the age of 5 years and pregnant women 
[1]. The clinical symptoms of malaria occur as a result of 
the erythrocytic stage of the parasite’s life cycle, due in part 
to inflammatory immune responses. The development of a 
blood-stage vaccine could potentially reduce the incidence 
of malaria. However, the development of such a vaccine faces 
many challenges, including the complexity of the immune re-
sponse and the lack of knowledge of the exact immune mech-
anism for parasite neutralization. The large number of parasite 
antigens to which the immune system is exposed, coupled 
with antigenic variation and polymorphism, makes the robust 
identification of specific targets of immunity against malaria 
difficult [2].
Two P falciparum protein families, erythrocyte-binding 
antigens (EBA) and reticulocyte binding-like homolog proteins 
(Rh), play an essential role in erythrocyte invasion [3, 4]. 
Because these proteins are important targets of immunity [5–
8], they have been evaluated as priority candidate antigens for 
developing a blood-stage vaccine [9–12]. However, variation in 
the utilization of diferent EBA and Rh proteins can mediate im-
mune escape [8], suggesting that vaccines may need to include 
multiple proteins to maximize eicacy.
Antibodies against EBA and Rh proteins have shown the 
ability to inhibit parasite growth in vitro [10, 13], supporting 
their importance as targets of immunity. Passive transfer of im-
munoglobulin (Ig)G from semi-immune adults to children with 
malaria can reduce parasitemia and mitigate symptoms [14, 15], 
so puriied IgG from adults may be useful in studying the targets 
of invasion inhibitory antibodies. In this study, antibodies in 
children with clinical malaria in 3 areas in Ghana with difering 
levels of endemicity were assayed against a panel of 9 EBA 
and Rh recombinant antigens and tested for correlations with 
age and levels of parasitemia. Separate analyses explored the 
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correlation between ability of puriied IgG to inhibit parasite 
growth in vitro and antibody reactivities to the antigens in 
semi-immune adults living in a highly endemic area of Ghana.
METHODS
Study Sites and Sampling
Children aged between 2 and 14 years with P falciparum slide-
positive clinical malaria were recruited in 3 ecologically distinct 
areas in Ghana: (1) Ledzokuku-Krowor municipality (LEKMA) 
in Accra, (2) Kassena and Nankana districts in northern Ghana, 
and (3) Kintampo Municipality in the middle belt of Ghana, as 
described in detail elsewhere [16, 17]. The local malaria transmis-
sion intensity as previously measured by the entomological inocu-
lation rates was highest in Kintampo (>250 infective bites/person 
per year), followed by Navrongo (<250 infective bites/person per 
year), and lowest in Accra (<50 infective bites/person per year) 
[18–20]. In addition, healthy adults living in Kintampo were 
sampled as representing a semi-immune population.
Informed written consent was obtained from adults and parents 
or guardians of children. In addition, informed written assent was 
obtained from children between 12 and 17 years of age. he study 
protocol received ethical approval ater review by the Institutional 
Review Board of the Noguchi Memorial Institute for Medical 
Research, University of Ghana and the Ethics Committee of the 
London School of Hygiene and Tropical Medicine. Venous blood 
from (1) children with malaria conirmed by rapid diagnostic test 
and microscopy and (2) healthy adults with no recent history of 
malaria was collected into tubes containing acid citrate dextrose, 
from which plasma was obtained.
Recombinant Antigens
A panel of 9 recombinant antigens based on sequences of key 
EBA and Rh merozoite invasion ligands was used for assays to 
study antibodies in plasma samples. Five of the antigens—re-
gions III–V of EBA140 (3D7; amino acids 770–1064), regions 
III–IV of EBA175 (3D7; amino acids 761–1298), a portion of 
the EBA181 sequence (3D7; amino acids 769–1365), Rh2.2030 
(3D7; amino acids 2027 to 2533, common region for both 
Rh2a and Rh2b), and Rh4.2 (amino acids 1277–1451)—
were expressed in Escherichia coli cells and purified using 
glutathione-agarose beads [21–23]. Four other antigens—full-
length ectodomains of EBA140, EBA175, EBA181, and Rh5—
were expressed as biotinylated proteins in HEK293E cells and 
purified by nickel affinity chromatography [24].
Enzyme-Linked Immunosorbent Assays
Enzyme-linked immunosorbent assays (ELISAs) were performed 
to determine levels of antigen-specific antibodies in plasma samples. 
Antibody reactivity to the GST-tagged antigens (EBA140 RIII–V, 
EBA175 RIII–V, EBA181 RIII–V, Rh2.2030, and Rh4.2) were meas-
ured as previously described for other GST-tagged antigens [25], 
whereas ELISAs using biotinylated antigens (full-length EBA140, 
EBA175, EBA181, and Rh5) were performed using methods previ-
ously described [26], with minor modifications.
In brief, 96-well plates (Immulon 4HBX; hermo Scientiic) 
were coated at 0.50 µg/mL of individual recombinant antigens 
(GST-tagged antigens) in coating bufer (15 mm Na
2
CO
3
, 35 mm 
NaHCO
3
, pH 9.3) and incubated overnight at 4°C. he plates 
were washed with phosphate-bufered saline (PBS) containing 
0.05% v/v Tween 20 (PBS-T) and blocked for 3 hours with 1% 
skimmed milk (Marvel UK, hame, UK) in PBS-T at room tem-
perature. For biotinylated antigens, streptavidin-coated 96-well 
ELISA plates (Nunc, Roskilde, Denmark) were washed with 
PBS-T and blocked for 30 minutes with PBS containing 0.5% 
bovine serum albumin at room temperature, before coating with 
individual recombinant antigens at 0.50 µg/mL. Antigen-coated 
plates were incubated at room temperature for 45 minutes. 
Plates were washed before addition of plasma samples diluted 
1:500 (GST-tagged antigens) and 1:1000 (biotinylated antigens) 
dilution in blocking bufer and incubated overnight at 4°C.
he plates were washed, incubated with horseradish peroxidase-
conjugated goat antihuman IgG (diluted 1/15 000) (Dako Ltd., Ely, 
UK), and washed again, before the addition of tetramethylbenzidine 
substrate solution. Ater incubation for 20 minutes, reactions were 
stopped using 0.2 M sulphuric acid, and optical densities (ODs) 
were measured at 450 nm in a microplate reader (Bio-Rad iMark, 
Hercules, CA). All plasma samples were assayed in duplicates, and 
any background OD in wells coated with GST only was subtracted 
from the antigen-speciic OD measurements.
Antibody reactivities of 20 nonimmune individuals (ma-
laria nonexposed Europeans) were tested as negative controls 
in all assays. Antibody reactivity of a test sample was considered 
positive if the OD was greater than the mean plus 3 standard 
deviations of these controls.
Purification of Total Immunoglobulin G
Total IgG was purified from 50 plasma samples using a protein 
G affinity column (GE Healthcare, Uppsala, Sweden), according 
to the manufacturer’s instructions. In brief, the column was 
equilibrated with 20  mM sodium phosphate buffer (pH 7.0), 
after which the diluted plasma samples were injected on the 
column. The column was washed with the equilibration buffer 
before eluting with 0.1 M glycine buffer (pH 2.8). Concentration 
of IgG fractions was determined using the Pierce Bicinchoninic 
acid Protein Assay Kit (Thermo Scientific, Rockford, IL).
Invasion Assays
Erythrocyte invasion assays were set up using schizont stage 
parasites according to methods described previously [27], with 
slight modifications. Parasite cultures with parasitemia between 
1% and 5% of predominantly schizont stage parasites (>90%) 
were used for invasion assays. These were set up by adding the 
parasite culture to carboxyfluorescein diacetate succinimidyl 
ester-stained erythrocytes at 2% hematocrit and purified IgG 
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at 5 mg/mL in a 96-well titer plate in duplicates. The plate was 
incubated at 37°C overnight in a gas mixture of 2% O
2
, 5.5% 
CO
2
, and 92.5% N
2
. Hoechst 33342 was used to stain parasite 
deoxyribonucleic acid to differentiate parasitized erythrocytes 
from uninfected erythrocytes, so that parasite invasion could be 
determined using flow cytometry on a BD Fortessa X-20.
Statistical Analyses
Statistical analyses were performed with Minitab (version 17). 
One-way analysis of variance or Kruskal-Wallis tests were applied 
for across-group comparisons for normally and nonnormally 
distributed data, respectively. Post hoc tests of Student t test or 
Mann-Whitney U tests were applied for pairwise analysis where 
necessary. Pearson and Spearman’s rank correlation coefficients 
were used to assess the association between 2 continuous variables. 
Multivariate regression analyses were carried out to determine 
which antigens predicted inhibitory activity. For all analyses, 
P < .05 was considered statistically significant.
RESULTS
Demographic Data and Parasitemia Levels of Children With Malaria
Plasma samples were obtained from 423 children with malaria 
in 3 different areas of Ghana. Children with malaria recruited 
in Accra (N = 125) were significantly older than those recruited 
in Navrongo (N = 131) (P =  .002) (Table 1). Ages of children 
recruited in Kintampo (N = 167) were not significantly different 
from those in Accra and Navrongo (P  =  .10 and P  =  .09, re-
spectively). There was no statistically significant difference in 
proportions of males and females sampled across sites (P = .42) 
(Table 1). Parasite densities differed significantly across sites 
(P < .001) (Table 1), with children from Kintampo showing the 
highest parasitemias, followed by Navrongo and then Accra, 
correlating with levels of malaria endemicity in these areas.
Antibody Responses of Children With Malaria to Invasion Antigens
To investigate the relationship between antimalarial antibodies 
and age, parasitemia, and levels of malaria endemicity, levels of 
antibodies to a panel of P falciparum invasion-related antigens 
were measured in plasma samples from malaria-positive children 
in Ghana. Antibody ELISA ODs against all antigens tested 
were compared across the 3 sites. Significant differences among 
the areas were observed for antibody levels (1) to full-length 
EBA181 and (2) to the partial-length recombinant proteins 
Rh2.2030 and Rh4.2. Antibody reactivity to full-length EBA181 
was higher in children from Kintampo (P = .003) (Figure 1A) 
and Navrongo (P = .003) (Figure 1A) compared with children 
from Accra. Likewise, antibody reactivity to Rh2.2030 was sig-
nificantly higher in children living in Kintampo compared with 
children living in Accra (P  =  .024) (Figure 1A), although no 
significant difference was observed in comparison to children 
from Navrongo (P > .05) (Figure 1A). In contrast, children in 
Accra showed higher antibody levels to Rh4.2 compared with 
children living in Navrongo and Kintampo (P  <  .05 for each 
comparison) (Figure 1A). There were no statistically significant 
differences across sites for the remaining antigens.
In endemic areas, age is oten a surrogate marker for ex-
posure, so we compared malaria-positive children of 2 age 
categories: ages 2–5 and 6–14  years old. he older age group 
had higher levels of IgG for all antigens, and these diferences 
were statistically signiicant for RIII–V of EBA140 and EBA175, 
and to full ectodomains of EBA175 and EBA181, as well as to 
Rh4.2 (P < .05 for all comparisons) (Figure 1B). Age-adjusted 
multivariate analysis was performed to determine the relation-
ship between antibody reactivity, parasite density and level of 
exposure, using transmission intensity as a marker of exposure. 
Antibody levels of EBA140 RIII-V, EBA181 RIII-V and PfRh5 
were signiicantly inluenced by level of exposure only (P < .001 
for all analyses; Table 2). Antibody levels to EBA181 FL were 
inluenced by both age (P = .003; Table 2) and level of expo-
sure (P < .001; Table 2). On the other hand, antibody levels to 
Rh2.2030 and Rh4.2 were signiicantly inluenced by parasite 
density (P = .002 for both antigens; Table 2) and level of expo-
sure (P = .026 and P = .037 respectively; Table 2).
Correlations Between Breadth of Antibody Reactivity, Age, Parasite 
Density, and Exposure Among Children
Previous studies have suggested that breadth of antibody 
reactivity is a correlate of protection and an important pre-
dictor of disease outcome, although combinations of specific 
Table 1. Clinical and Demographic Characteristics of Malaria-Positive Ghanaian Children Aged 2–14 Years in Kintampo, Navrongo, and Accra at the Time 
of Samplinga
Characteristics Kintampo Navrongo Accra Total P Value
Number of subjects 167 131 125 423 .419b
 Female (%) 46.70 52.10 43.50 47.50 
Age in years, mean (SE) 5.7 (0.3) 5.1 (0.3) 6.4 (0.3) 5.7 (0.2) .009c
Parasitemia per µL, mean (SE) 137 824 (17 297) 46 863 (4533) 41 184 (3876) 82 189 (7601) <.001c
Abbreviations: ANOVA, analysis of variance; SE, standard errors of the mean.
aRelative malaria transmission intensities as measured by entomological inoculation rates in the areas are in the order Kintampo > Navrongo > Accra. Data for age and parasitemia are 
presented as means (with SE).
b
P value obtained from χ2 test.
c
P value obtained from ANOVA.
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antibody responses are more strongly associated with pro-
tection [9, 26, 28]. Breadth was estimated as the number 
of recombinant antigens recognized (IgG reactivity above 
the determined ELISA cutoff level) for each child. The dis-
tribution of breadth of antibody reactivity was compared 
across the 3 endemic areas. The distribution in Kintampo 
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Figure 1. (A) Invasion antibody proiles of children with malaria across 3 endemic regions of Ghana. Antibody reactivity of malaria-positive children to erythrocyte-binding 
antigen (EBA) and reticulocyte binding-like homolog proteins (Rh) between Kintampo (N = 167), Navrongo (N = 131), and Accra (N = 125). *, Group means differ signiicantly 
(P < .05, Student’s t test). (B) Age-dependent acquisition of immunoglobulin (Ig)G against recombinant EBA and Rh proteins. The IgG reactivity of malaria-positive children 
(N = 423) to the antigens were grouped to 2 age groups: 2–5 years and 6–14 years. Bars represent group means, and error bars represent standard errors of the means. *, 
Group means differ signiicantly (P < .05, Student’s t test). ELISA, enzyme-linked immunosorbent assay; FL, full length; OD, optical density.
Table 2.  Multiple Linear Regression Analysis of Factors Associated With Anti-Merozoite Antibody Levels in Malaria-Positive Children
Antigens
Age Parasite Density Level of exposure
F P-value F P-value F P-value
EBA140 RIII-V 1.62 .203 0.08 .774 6.96 .001a
EBA140 FL 1.55 .214 2.36 .125 1.09 .336
EBA175 RIII-V 0.14 .704 2.22 .137 1.59 .205
EBA175 FL 3.05 .082 9.01 .003a 1.22 .297
EBA181 RIII-V 1.7 .193 1.29 .257 10.26 <.001a
EBA 181 FL 9.26 .003
a 1.44 .231 12.89 <.001a
Rh2 0.14 .705 10.22 .002a 3.68 .026
Rh4 0.21 .651 6.17 .002a 4.39 .037
Rh5 FL 1.25 .265 0.06 .807 12.77 <.001a
Table summarizing the multiple linear regression analyses. Antibody levels were the outcome variables, while age, parasitaemia, and transmission intensity (level of exposure) were the pre-
dictor variables. F = F-statistic. Statistically signiicant predictors are shown in bold face. 
aSigniicant after Bonferroni’s P value adjustment. FL=full-length.
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was peaked, approaching a normal distribution with most 
children recognizing 2–4 antigens (skewness  =  0.60, kur-
tosis  =  −0.16) (Figure 2A). The distribution in Navrongo 
showed almost no peak, with an even spread of antigens 
recognized (skewness = 0.19, kurtosis = −0.99) (Figure 2B). 
In contrast, for samples from Accra, the distribution showed 
a left skewed peak (skewness = 0.75, kurtosis = −0.65) (Figure 
2C), with most children recognizing less than 3 antigens. 
In addition, breadth of antibody reactivity was positively 
correlated with age (ρ = 0.201, P < .001). Regression analysis 
showed that the strongest predictors of breadth of antibody 
reactivity were age (F = 24.01, P < .001) and endemic area of 
sampling (F = 4.80, P = .009).
Percentage seropositivity of children (IgG reactivity above 
the cutof levels) for each of the 9 antigens tested was compared 
for the malaria cases recruited across the 3 endemic sites. 
We observed no signiicant diference in the prevalence of 
antibodies to RIII–V of EBA140, EBA175, EBA181, and full-
length Rh5 (P  >  .05 for all comparisons) (Supplementary 
Figure 1). However, the proportion seropositive for full-length 
EBA140, EBA175, EBA181, Rh2.2030, and Rh4.2 difered sig-
niicantly between the 3 sites, with Accra showing the lowest 
proportions for all antigens (P  <  .05 for all comparisons) 
(Supplementary Figure 1).
Antibody Reactivity to Merozoite Antigens in Adult Donors
Plasma IgG reactivity of the adult donors to the same 9 recom-
binant antigens was also determined (Figure 3A). All 50 donors 
were seropositive against 1 or more of the antigens: EBA140 
RIII–V (96%), full-length EBA140 (42%), EBA175 RIII–V 
(78%), full-length EBA175 (60%), EBA181 RIII–V (42%), 
full-length EBA181 (62%), Rh2 (42%), Rh4 (28%), and Rh5 
(26%). Antibody OD levels to full-length and RIII–V fragment 
antigens were strongly correlated with one another for EBA175 
(R = 0.779, P < .001) and EBA140 (R = 0.641, P < .001), whereas 
antibody levels to full-length and fragment antigens of EBA181 
showed weaker correlation (R = 0.354, P = .012). No association 
was found between donor age and ELISA ODs for any of the 
antigens tested.
Invasion Inhibitory Activity of Purified Immunoglobulin G Fractions 
From Adults
Given the relationship between parasite density and antibody 
levels observed in children, we sought to further examine the re-
lationship between antibody reactivity to EBA and Rh antigens 
and functional activity. In vitro invasion inhibitory assays were 
performed using purified IgG from adults against 4 laboratory-
adapted strains (3D7, W2mef, K1, and GB4) and 3 local clinical 
isolates from Kintampo (EIMK084, EIMK239, and EIMK244). 
There was sufficient purified IgG amount from 36 of the donors 
for performing assays on all 7 parasite lines. Across the different 
lines, purified IgG from individual donors showed an average in-
vasion inhibitory ability of 15%, ranging between 10% and 40% 
for individual IgG samples (Figure 3B). There were differences 
in the levels of inhibition measured for the assays performed 
on different parasite lines (Supplementary Figure 2). For ex-
ample, the laboratory isolate 3D7 was significantly inhibited 
by IgG from donors EIMKB33 and EIMKB20 compared with 
the control (Supplementary Figure 2A and B), whereas W2mef 
was inhibited by IgG from most individuals. Immunoglobulin 
G had generally less inhibitory effects in the assays performed 
on parasite isolates GB4 and K1 (Supplementary Figure 2C and 
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Figure 2. The breadth of antibody reactivity to multiple antigens varies across 
areas with varying transmission intensity. Breadth scores were calculated for each 
child based on the number of antibody responses. Distribution of the breadth of 
antibody reactivity of malaria-positive children was compared between Kintampo 
(N = 167), Navrongo (N = 131), and Accra (N = 125).
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D). Comparing the 3 local parasite isolates, there was more IgG 
inhibition seen against isolate EIMK239 than isolate EIMK084 
and EIMK244 (Supplementary Figure 2E–G). It is unknown 
whether these differences are due to actual intrinsic variation 
among the isolates, because each one was not assayed with mul-
tiple independent biological preparations. For the measurement 
of invasion inhibition overall, the mean of the inhibitory activity 
across all 7 isolates was considered in the subsequent analysis.
Antibody Reactivity Is Correlated With Invasion Inhibition
Next, we examined the relationship between antibody reactivity 
and invasion inhibitory activity in cultured parasites. Breadth 
of antibody reactivity was calculated based on the number of 
antigens to which the individual was seropositive (Figure 4A). 
Although the breadth of antibody response was not correlated 
with age in adults (Spearman’s rho = −0.011, P =  .94) (Figure 
4B), a significant association was observed between breadth of 
antibody reactivity and invasion inhibitory activity (Spearman’s 
rho  =  0.437, P  =  .010) (Figure 4C). Furthermore, antibody 
ELISA OD levels against each of the individual antigens were 
significantly correlated with invasion inhibition (P  <  .05 for 
each analysis) (Figure 5).
To explore which speciic antigen combinations were associ-
ated with the observed invasion inhibitory activity, we grouped 
the antigens into 2-, 3-, 4-, and 5-way combinations and 
obtained a breadth score for each combination for each donor, 
based on seropositivity. he breadth scores for each combina-
tion were then correlated with mean invasion inhibitory ac-
tivity. Several combinations were signiicantly correlated with 
invasion inhibition. In general, combinations that included Rh 
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Figure 3. (A) Antibody enzyme-linked immunosorbent assay (ELISA) optical densities (ODs) for serum immunoglobulin (Ig)G against erythrocyte-binding antigen (EBA) 
and reticulocyte binding-like homolog protein (Rh) antigens in plasma from Ghanaian adult donors. The ELISA assays were conducted using plasma collected from 50 semi-
immune adults residing in Kintampo. Data are presented as dot plots. Lines represent medians. Error bars represent interquartile ranges. (B) Average growth inhibitory 
activity of puriied IgG from adult donors against 7 Plasmodium falciparum isolates. Growth inhibition assays were set up in duplicate in 96-well plates to test the inhibitory 
activity of 36 puriied IgG preparations (at 5 mg/mL) from semi-immune adults living in Kintampo. Four laboratory strains (3D7, W2Mef, K1, and GB4) and 3 clinical isolates 
(EIMK084, EIMK239, and EIMK244) were tested. Parasitemia was determined by low cytometry using BD FACS Fortessa. Data are presented as a percentage of invasion 
eficiency in comparison to the uninhibited control. Error bars represent standard errors of the means. *, Invasion inhibition by puriied IgG is statistically signiicant relative 
to uninhibited control (P < .05, Student’s t test).
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proteins showed strong association with invasion inhibitory ac-
tivity. Ater Bonferroni correction, a 3-way combination of Rh2, 
Rh4, and Rh5 was the most strongly correlated with invasion 
inhibition (R = 0.55; uncorrected P = .00068, corrected P < .05) 
(Supplementary Table 1).
DISCUSSION
It has previously been shown that antibodies against P falcip-
arum merozoite EBA and Rh proteins have greater inhibitory 
effect against parasites in culture when used in combina-
tion [10], supporting the idea that antibodies against multiple 
antigens can act in combination to provide protection against 
malaria. Effective naturally acquired immunity may require 
the development of substantial antibodies to multiple EBA 
and PfRh antigens. The present study was designed to examine 
the patterns and repertoire of responses to merozoite invasion 
antigens in relation to age, exposure, and parasite density in 
children with malaria. In addition, the relationship between the 
ability of purified IgG to inhibit parasite growth in vitro and the 
antibody reactivities to EBA and Rh antigens in semi-immune 
adults living in an endemic area of Ghana was examined.
Antibody levels to diferent antigens were weakly or mod-
erately correlated with one another, as previously observed 
elsewhere [9, 26]. Consistent with previous studies, propor-
tion of seropositive individuals against the Rh proteins, espe-
cially Rh4 and Rh5, were generally lower than EBA proteins 
[6, 9]. Antibody levels also varied signiicantly across trans-
mission areas, with some increasing with transmission inten-
sity, whereas others decreased. It has been proposed that the 
diferences observed in the rates of acquisition of antibodies to 
merozoite antigens may be due to diferences in the immunoge-
nicity as well as the subcellular localization of the antigens [29]. 
It is known that antibodies acquired during a malaria transmis-
sion season can be lost at diferent rates over the course a subse-
quent dry season when there is little to no malaria transmission 
[30–32]. It has been suggested that the rates of acquisition of 
antibodies are antigen-speciic, and diferent antigens may elicit 
antibody-secreting cells with diferent longevity [29, 33].
Breadth of antibody reactivity to multiple antigens is asso-
ciated with reduced risk of clinical malaria and is a correlate 
of protective immunity [34], and combined antibodies to EBA 
and Rh antigens have been strongly associated with protective 
immunity [9]. A  previous study showed that breadth of anti-
body response increased with age, suggesting that acquisition 
of humoral immunity requires repeated exposure to malaria 
infection [35]. Similar to their inding, breadth of reactivity 
correlated with age in children with malaria in our study, 
and that the area of lowest endemicity (Accra) had the lowest 
breadth of reactivity per individual.
Growth inhibitory activity of puriied IgG from a panel 
of adult donors living in a malaria-endemic area was deter-
mined against 7 parasite lines. Consistent with what has pre-
viously been reported with IgG from immune donors [36], 
varying levels of inhibitory activity were observed across 
donors. A previous study in Kenya reported that plasma levels 
of antibodies to merozoite surface protein (MSP)3 correlated 
with growth inhibitory activity against 3 laboratory strains 
[37]. In the present study, average invasion inhibitory activity 
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Figure 4. (A) The breadth of antibody reactivity of semi-immune adults from 
Kintampo against multiple Plasmodium falciparum antigens. Breadth scores were 
calculated for each adult based on the number of antigens recognized by plasma 
immunoglobulin (Ig)G from individual donors. Individual antigens are as labeled 
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inhibition of puriied IgG when tested against 7 parasite lines in culture (as shown 
in Supplementary Figure S2). Correlations of P < .05 were considered statistically 
signiicant by Spearman rank test.
8 • OFID • Mensah-Brown et al
against 7 parasite lines was signiicantly positively correlated 
with antibody reactivity for each of the EBA and Rh recombi-
nant antigens tested. Furthermore, a combination of antibodies 
against Rh2, Rh4, and Rh5 emerged as the strongest predictor 
of overall with growth inhibitory activity against the parasite 
strains tested.
Puriied IgG from some samples seemed to slightly enhance 
the growth of some parasite lines in vitro, a phenomenon that 
has previously been reported in other studies, but the mech-
anism is currently unknown. Some antibodies to recombinant 
antigens have been shown to enhance merozoite invasion in 
vitro [38], and it has also been reported that pooled IgG from 
West African donors enhanced parasite growth in vitro [14]. 
Another study showed that the majority of IgG preparations 
from Kenyan donors enhanced parasite growth by varying 
degrees [39]. It is diicult to determine what could account for 
this enhancement of growth, but antibody-mediated enhance-
ment of infection has been reported in other pathogens such 
as human immunodeiciency virus and dengue fever [40, 41]. 
Recent studies suggested that complement interactions were 
important for mediating the inhibitory activity of acquired 
antibodies for many individuals, and invasion enhancement was 
not prominent if complement was present [42]. Complement-
mediated enhancement of parasite growth has also been re-
ported in P falciparum using a mouse monoclonal antibody 
against MSP1 [43].
he present analysis showed that breadth of antibody reac-
tivity to multiple antigens was associated with inhibitory ac-
tivity of puriied IgG, and the individual speciic antibody levels 
were also correlated with inhibition. Results from a birth co-
hort study in Kenya indicated that there was growth inhibitory 
activity by IgG but that this did not increase with increasing 
breadth of antibody reactivity by ELISA [37]. However, our 
observations support those of others that suggest that breadth 
of antibody reactivity against diferent antigens is a key deter-
minant of protection against malaria [2, 28, 44]. One study [45] 
suggested that parasites grown in the presence of antibodies 
against 2 vaccine candidate antigens led to the emergence of 
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clones that showed reduced sensitivity to antibody-mediated 
parasite inhibition. Although such possible selection has not 
been studied independently, if this efect is real, it would indi-
cate that a multicomponent vaccine may be desirable to prevent 
the emergence of vaccine resistance.
CONCLUSIONS
he data presented in this study contribute further evidence 
in support of using combinations of 2 or more antigens in a po-
tential blood-stage vaccine. Furthermore, our analysis suggests 
that 3 antigens are optimal, and combinations of Rh2, Rh4, and 
Rh5 emerged as a potential efective combination.
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